Pulmonary Function Testing (PFT) is a vital tool in diagnosing and managing respiratory diseases. However, interpreting the results can be complex for healthcare professionals. This guide aims to simplify the process.
Spirometry, the most common PFT, measures the amount (volume) and speed (flow) of air that can be inhaled and exhaled. Key values include Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and their ratio (FEV1/FVC). Abnormalities in these values can indicate obstructive or restrictive lung diseases.
Obstructive disorders, such as COPD and asthma, are characterized by reduced airflow. This is reflected in a decreased FEV1/FVC ratio. On the other hand, restrictive disorders like pulmonary fibrosis present with reduced lung volumes (FVC), but normal or increased FEV1/FVC ratio.
Gas exchange tests, such as the diffusion capacity for carbon monoxide (DLCO), provide insight into the lung’s ability to transfer gases between the alveoli and the bloodstream. Reduced DLCO can indicate diseases like emphysema or pulmonary hypertension.
Interpretation of PFT results should always be integrated with the patient's symptoms, physical examination, and other diagnostic tests. For instance, a reduced FEV1/FVC ratio accompanied by wheezing and episodic breathlessness may suggest asthma.
Interpreting PFT results is a nuanced process that requires a comprehensive understanding of respiratory physiology and clinical context. By understanding spirometry and gas exchange testing, and recognizing obstructive and restrictive patterns, healthcare professionals can more accurately diagnose and manage respiratory diseases.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation